Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,291,272
-
Share change
-
-372,105
-
Total reported value
-
$1,304,124,623
-
Put/Call ratio
-
41%
-
Price per share
-
$91.25
-
Number of holders
-
68
-
Value change
-
-$29,166,527
-
Number of buys
-
27
-
Number of sells
-
33
Institutional Holders of CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) as of Q1 2019
As of 31 Mar 2019,
CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,291,272 shares.
The largest 10 holders included
HILLHOUSE CAPITAL ADVISORS, LTD., Capital Research Global Investors, HSBC HOLDINGS PLC, BANK OF AMERICA CORP /DE/, York Capital Management Global Advisors, LLC, Temasek Holdings (Private) Ltd, VANGUARD GROUP INC, FIL Ltd, Greenwoods Asset Management Ltd, and FMR LLC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.